(Q40363040)

19 September 2017

title

Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates (English)

1 reference

19 September 2017

0 references

1 reference

Kenneth L Roland

1

1 reference

19 September 2017

Steven A Tinge

2

1 reference

19 September 2017

Sims K Kochi

3

1 reference

19 September 2017

Lawrence J Thomas

4

1 reference

19 September 2017

Kevin P Killeen

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

23 March 2010

1 reference

19 September 2017

1 reference

19 September 2017

volume

28

1 reference

19 September 2017

issue

21

1 reference

19 September 2017

page(s)

3679-3687

1 reference

Putting typhoid vaccination on the global health agenda

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Salmonella paratyphi A rates, Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Paratyphoid fever in India: An emerging problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Spectrum of disease and relation to place of exposure among ill returned travelers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Enteric fever due to Salmonella typhi and paratyphi A a neglected and emerging problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Drug-resistant Salmonella enterica serotype paratyphi A in India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Urgent need for effective vaccine against Salmonella paratyphi A, B and C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Can needle-free administration of vaccines become the norm in global immunization?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Vaccines against typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

The Salmonella typhi melittin resistance gene pqaB affects intracellular growth in PMA-differentiated U937 cells, polymyxin B resistance and lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

PhoP/Q regulated genes in Salmonella typhi identification of melittin sensitive mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Salmonella enterica serovar Choleraesuis derivatives harbouring deletions in rpoS and phoP regulatory genes are attenuated in pigs, and survive and multiply in porcine intestinal macrophages and fibroblasts, respectively.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

The regulatory protein PhoP controls susceptibility to the host inflammatory response in Shigella flexneri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

An essential role for phoP in Mycobacterium tuberculosis virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Genetic determinants and polymorphisms specific for human-adapted serovars of Salmonella enterica that cause enteric fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Relationship between the Tsh autotransporter and pathogenicity of avian Escherichia coli and localization and analysis of the Tsh genetic region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Allelic exchange in Escherichia coli using the Bacillus subtilis sacB gene and a temperature-sensitive pSC101 replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

The purB gene of Escherichia coli K-12 is located in an operon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Escherichia coli purB gene: cloning, nucleotide sequence, and regulation by purR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Bacteremia associated with live attenuated chi8110 Salmonella enterica serovar Typhi ISP1820 in healthy adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Use of paired serum samples for serodiagnosis of typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Distribution of antibody titer against Salmonella enterica among healthy individuals in nepal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Adaptive acidification tolerance response of Salmonella typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

Further characterization of the PhoP regulon: identification of new PhoP-activated virulence loci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

7 January 2021

Evolutionary genetic relationships of clones of Salmonella serovars that cause human typhoid and other enteric fevers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

7 January 2021

Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

7 January 2021

Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

7 January 2021

Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.019

7 January 2021

10.1016/J.VACCINE.2010.03.019

Identifiers

DOI

1 reference

19 September 2017

1 reference